Anywhere from 35 to 50% of B-UNC/BL/DLBCL cases have C-MYC translocations and about 15% of these are accompanied by either BCL2 or BCL6 rearrangements. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.